By contrast, the reduced expression and activity of GSTP1 are observed due to the hypermethylation of its promoter in hepatocellular carcinoma (HCC) and prostate cancer (9–10), although GSTP1 may also be detected in the corresponding non-tumorous tissues. Here, GSTP1 is linked to prostate carcinoma.